The MAD can quickly and effectively deliver the exact dosing and exact volume of atomized nasal medications to both children and adults without needing IV set-up time or a sterile technique. Since there’s no shot and no needle, the MAD avoids the risk of needlestick injury and helps keep patients and caregivers safe.

The MAD is designed to atomize in any position, and the atomized particles it delivers are the optimal size for deposition across a broad area of mucosa. The atomized nasal medications rapidly absorb across olfactory mucosal membranes to the bloodstream into the brain and cerebrospinal fluid. This absorption method thus avoids first-pass metabolism.

With its controlled administration and simple delivery system, the MAD Intranasal Mucosal Atomization Device is appropriate for both ALS and BLS.

• MAD quickly and effectively delivers the exact dosing and exact volume of atomized nasal medications to both children and adults
• Device can be used without needing IV set-up time or a sterile technique
• Device avoids the risk of needlestick injury because it doesn’t use a needle, thus helping keep patients and caregivers safe
• MAD atomizes in any position
• Atomized particles are the optimal size for deposition across a broad area of mucosa
• Atomized nasal medications rapidly absorb across olfactory mucosal membranes to the bloodstream into the brain and cerebrospinal fluid, thus avoiding first-pass metabolism
• Device is titratable to effect and approaches medication levels comparable to injections
• Controlled administration and simple delivery system make the device appropriate for both ALS and BLS